Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|January 8, 2021
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinomaPedro Rocha, Ruth Salazar, Jiexin Zhang, et al.
Cell Chemical Biology|December 30, 2019
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung CancerPaul Yenerall, Amit K Das, Shan Wang, et al.
The Journal of Clinical Investigation|February 10, 2015
Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stromaYulong Chen, Masahiko Terajima, Yanan Yang, et al.
Cancer Research|May 5, 2011
Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cellsMarc Damelin, Kenneth G Geles, Maximillian T Follettie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 19, 2020
STING Pathway Expression Identifies NSCLC With an Immune-Responsive PhenotypeCarminia M Della Corte, Triparna Sen, Carl M Gay, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to DasatinibIrati Garmendia, María J Pajares, Francisco Hermida-Prado, et al.
Cell Reports|May 25, 2017
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase InhibitorsMaithili P Dalvi, Lei Wang, Rui Zhong, et al.
Nature Communications|December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristicsMing Tang, Hussein A Abbas, Marcelo V Negrao, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2020
18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancerKyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Pageof 17